Tissium
France - ParisBiotechnology
Focus: Tissium is a French biotech specializing in synthetic polymers for vascular sealing and tissue repair devices, operating as a publicly traded company with a focused cardiovascular and surgical device portfolio.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Tissium?
AI assessmentTissium offers deep technical specialization in a niche market but shows limited hiring and unclear financial footing—suit early-stage researchers willing to build IP but not those seeking rapid career growth.
Why Work Here
- Rare focus on synthetic polymer technology—a differentiated platform with limited direct competition in vascular sealing
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TISSIUM™ Nerve Coaptation Device
Digital Nerve InjuryClinical Trials (1)
NCT04327154TISSIUM's Nerve Coaptation Device First-in-Human Clinical Trial
N/AHelp build intelligence for Tissium
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.